Cardiotoxicity related to intrapericardial infusion of bevacizumab in the treatment of lung cancer-mediated malignant pericardial effusion: a case report

BackgroundLung cancer can result in malignant pericardial effusion (MPE), impacting patient prognosis. Intrapericardial infusion of bevacizumab was an alternative treatment for MPE.Case presentationWe present the case of a 48-year-old female with stage IV lung adenocarcinoma and MPE. MPE was managed...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shilong Wu, Yanjun Lu, Chenyang Xu, Huafeng Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-10-01
Edice:	Frontiers in Pharmacology
Témata:	bevacizumab cardiotoxicity myocardial ischemia lung cancer malignant pericardial effusion
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1573297/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!